Christine Fox

Insider Reports History

Location
London, United Kingdom
Signature
/s/ Christine Fox
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Christine Fox:

Company Role Class Num Shares Value Price $ Report Date Ownership
Mereo BioPharma Group plc Chief Financial Officer Share Options (Right to buy) 280,000 $264,620 $1.01 01 Feb 2026 Direct

Insider Reports Filed by Christine Fox

Symbol Company Period Transactions Value $ Form Type Role Filing Time
MREO Mereo BioPharma Group plc 01 Feb 2026 3 $0 4 Chief Financial Officer 02 Feb 2026, 16:30
MREO Mereo BioPharma Group plc 25 Jan 2025 1 $0 4 Chief Financial Officer 28 Jan 2025, 16:05
MREO Mereo BioPharma Group plc 12 Sep 2024 2 -$121,693 4 Chief Financial Officer 16 Sep 2024, 20:47
MREO Mereo BioPharma Group plc 11 Sep 2024 2 $0 4 Chief Financial Officer 13 Sep 2024, 16:50
MREO Mereo BioPharma Group plc 25 Jun 2024 2 -$147,876 4 Chief Financial Officer 27 Jun 2024, 16:15
MREO Mereo BioPharma Group plc 21 Jun 2024 2 $0 4 Chief Financial Officer 25 Jun 2024, 18:13
MREO Mereo BioPharma Group plc 25 Jan 2024 1 $0 4 Chief Financial Officer 26 Jan 2024, 16:15
MREO Mereo Biopharma Group plc 01 Jan 2024 0 $0 3 Chief Financial Officer 02 Jan 2024, 16:15